Testing effectiveness (Phase 2)Ended earlyNCT00554775What this trial is testingWBRT & Erlotinib in Advanced NSCLC and Brain MetastasesWho this might be right forLung CancerMetastatic Cancer University College, London 80
Early research (Phase 1)Study completedNCT00003395What this trial is testingArsenic Trioxide in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00098891What this trial is testingMS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+41 more National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00005639What this trial is testingAzacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TreatmentWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Testing effectiveness (Phase 2)Study completedNCT02312622What this trial is testingPhase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast CancerWho this might be right forStage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more Joel Neal 27
Testing effectiveness (Phase 2)Looking for participantsNCT05948813What this trial is testingTY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain MetastasesWho this might be right forNSCLCEGFR Activating MutationBrain Metastases TYK Medicines, Inc 420
Early research (Phase 1)Ended earlyNCT03656627What this trial is testingNivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseWho this might be right forAutoimmune DiseasesNon-small Cell Lung CancerRheumatoid Arthritis+7 more Alliance Foundation Trials, LLC. 7
Not applicableStudy completedNCT06321510What this trial is testingLearn About Dacomitinib in Patients With Non-small Cell Lung Cancer.Who this might be right forLung Cancer Pfizer 29
Testing effectiveness (Phase 2)Ended earlyNCT03207867What this trial is testingNIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaWho this might be right forNSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more Novartis Pharmaceuticals 315
Early research (Phase 1)Study completedNCT00293345What this trial is testing3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more National Cancer Institute (NCI) 30
Early research (Phase 1)UnknownNCT00003073What this trial is testingChemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid TumorsWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+1 more Pacira Pharmaceuticals, Inc 15
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Early research (Phase 1)Study completedNCT01421524What this trial is testingStudy of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple MyelomaWho this might be right forMultiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more Celgene 271
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT05865990What this trial is testingHER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal DiseaseWho this might be right forMetastatic Breast CancerAdvanced Non-Small Cell Squamous Lung CancerSolid Tumor, Adult MedSIR 63
Testing effectiveness (Phase 2)Study completedNCT03213691What this trial is testingSelumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+8 more National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)UnknownNCT02927340What this trial is testingLorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial LesionsWho this might be right forNon-Small Cell Lung Cancer (NSCLC) Massachusetts General Hospital 30
Early research (Phase 1)Study completedNCT00004189What this trial is testingRebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced CancerWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00049712What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific University of Wisconsin, Madison